Malin Corporation plc Total Liabilities

Latest as of December 2024: €5.30 Million EUR ≈ $6.20 Million USD

Malin Corporation plc total liabilities. Based on the latest financial reports, Malin Corporation plc (MLC) has total liabilities worth €5.30 Million EUR (≈ $6.20 Million USD) as of December 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See operational self-sufficiency of Malin Corporation plc to measure how many days the company can operate on defensive assets alone.

Total Liabilities of Malin Corporation plc (2015–2024)

Total liabilities of Malin Corporation plc from 2015 to 2024. This chart illustrates how Malin Corporation plc's total liabilities have evolved over time, based on quarterly financial data. Check Malin Corporation plc (MLC) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Malin Corporation plc Competitors by Total Liabilities

The table below lists competitors of Malin Corporation plc ranked by their total liabilities.

Company Country Total Liabilities
Bubang Co. Ltd
KQ:014470
Korea ₩81.19 Billion
Urban One Inc Class D
NASDAQ:UONEK
USA $642.06 Million
Berlina Tbk
JK:BRNA
Indonesia Rp1.14 Trillion
P-Two Industries
TWO:6158
Taiwan NT$1.23 Billion
Apollomics Inc. Class A Ordinary Shares
NASDAQ:APLM
USA $9.90 Million
TBH Global Co Ltd
KO:084870
Korea ₩42.22 Billion
Imperial Equities Inc.
V:IEI
Canada CA$126.14 Million
Scanwolf Corporation Bhd
KLSE:7239
Malaysia RM135.22 Million

Liability Composition Analysis (2015–2024)

This chart breaks down Malin Corporation plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Malin Corporation plc (MLC) total assets.

Liquidity & Leverage Metrics

Malin Corporation plc Total Liabilities Ratios Explained

Malin Corporation plc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 62.60 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.03 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.03 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Malin Corporation plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Malin Corporation plc (2015–2024)

The table below shows the annual total liabilities of Malin Corporation plc from 2015 to 2024.

Year Total Liabilities Change
2024-12-31 €5.30 Million
≈ $6.20 Million
-25.35%
2023-12-31 €7.10 Million
≈ $8.30 Million
+47.92%
2022-12-31 €4.80 Million
≈ $5.61 Million
-48.39%
2021-12-31 €9.30 Million
≈ $10.87 Million
-88.45%
2020-12-31 €80.50 Million
≈ $94.11 Million
-13.16%
2019-12-31 €92.70 Million
≈ $108.38 Million
-1.38%
2018-12-31 €94.00 Million
≈ $109.90 Million
+8.55%
2017-12-31 €86.60 Million
≈ $101.24 Million
-8.65%
2016-12-31 €94.80 Million
≈ $110.83 Million
+61.22%
2015-12-31 €58.80 Million
≈ $68.74 Million
--

About Malin Corporation plc

IR:MLC Ireland Drug Manufacturers - Specialty & Generic
Market Cap
$30.09 Million
€25.74 Million EUR
Market Cap Rank
#23609 Global
#20 in Ireland
Share Price
€5.95
Change (1 day)
+0.00%
52-Week Range
€5.95 - €8.30
All Time High
€15.37
About

Malin Corporation plc, through its subsidiaries, operates in the life sciences industry in Ireland and the United States. It also engages in investment activities. The company was incorporated in 2014 and is headquartered in Dublin, Ireland.